Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2'-cyano-2'-deoxyarabinofuranosylcytosine
2. 2'-cyano-2'deoxy-1-beta-d-arabinofuranosylcytosine
1. 135598-68-4
2. Tas-109
3. Radgocitabine
4. (2r,3s,4s,5r)-2-(4-amino-2-oxopyrimidin-1-yl)-4-hydroxy-5-(hydroxymethyl)oxolane-3-carbonitrile
5. Tas 109
6. 00m634hd2v
7. 2'-cyano-2'-deoxy-1-(beta-d-arabinofuranosyl)cytosine
8. (2r,3s,4s,5r)-2-(4-amino-2-oxopyrimidin-1(2h)-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-carbonitrile
9. Unii-00m634hd2v
10. Radgocitabine [who-dd]
11. Radgocitabine [inn]
12. Chembl337450
13. Schembl1006241
14. Dtxsid30159474
15. Chebi:145435
16. Dfp10917
17. Ex-a1611
18. Hy-16445a
19. 4-amino-l-(2-cyano-2-deoxy-beta-d-arabinofuranosyl)- 2(1h)-pyrimidinone
20. Akos030573293
21. Cs-6837
22. Db11667
23. Ns00069241
24. A857813
25. 1-(2-deoxy-2-cyano-beta-d-arabinofuranosyl)cytosine
26. Q27231358
27. 1-(2-c-cyano-2-deoxy-beta-d-arabino-pentofuranosyl) Cytosine
28. 2'-c-cyano-2'-deoxy-1-beta-d-arabino-pentofuranosyl-cytosine
29. 2'-cyano-2'-deoxy-1-(.beta.-d-arabinofuranosyl)cytosine
30. 4-amino-1-(2-cyano-2-deoxy-beta-d-arabinofuranosyl)pyrimidin-2(1h)-one
31. 2(1h)-pyrimidinone, 4-amino-1-(2-cyano-2-deoxy-.beta.-d-arabinofuranosyl)-
32. 4-amino-l-(2-cyano-2-deoxy-.beta.-d-arabinofuranosyl)- 2(1h)-pyrimidinone
33. (2r,3s,4s,5r)-2-(4-amino-2-oxopyrimidin-1(2h)-yl)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-3-carbonitrile
| Molecular Weight | 252.23 g/mol |
|---|---|
| Molecular Formula | C10H12N4O4 |
| XLogP3 | -2.4 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 132 |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 466 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
95
PharmaCompass offers a list of Radgocitabine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Radgocitabine manufacturer or Radgocitabine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Radgocitabine manufacturer or Radgocitabine supplier.
PharmaCompass also assists you with knowing the Radgocitabine API Price utilized in the formulation of products. Radgocitabine API Price is not always fixed or binding as the Radgocitabine Price is obtained through a variety of data sources. The Radgocitabine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Radgocitabine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Radgocitabine, including repackagers and relabelers. The FDA regulates Radgocitabine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Radgocitabine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Radgocitabine supplier is an individual or a company that provides Radgocitabine active pharmaceutical ingredient (API) or Radgocitabine finished formulations upon request. The Radgocitabine suppliers may include Radgocitabine API manufacturers, exporters, distributors and traders.
Radgocitabine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Radgocitabine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Radgocitabine GMP manufacturer or Radgocitabine GMP API supplier for your needs.
A Radgocitabine CoA (Certificate of Analysis) is a formal document that attests to Radgocitabine's compliance with Radgocitabine specifications and serves as a tool for batch-level quality control.
Radgocitabine CoA mostly includes findings from lab analyses of a specific batch. For each Radgocitabine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Radgocitabine may be tested according to a variety of international standards, such as European Pharmacopoeia (Radgocitabine EP), Radgocitabine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Radgocitabine USP).
